查找地点
有关时间、上门服务和预约Labcorp believes in harnessing science to improve the health and lives of people with neurodegenerative diseases, such as Alzheimer’s and multiple sclerosis.
NfL is a well-studied blood biomarker test that is now widely available through Labcorp for assessing neuronal damage from neurodegenerative diseases and sports-related concussion.
GFAP is a protein expressed mostly in astrocytes in the brain that has utility in predicting disability progression in multiple sclerosis, determining the extent of damage in traumatic brain injury events and, in conjunction with markers of amyloid pathology, has been shown to be a predictor of Alzheimer’s disease.
Finding a way to diagnose Alzheimer's earlier and easier is a key goal for Labcorp.
While no single test can diagnose multiple sclerosis, lab tests may help doctors rule out other diseases and confirm a diagnosis.
Genetics can play a significant role in the development of certain neurodegenerative diseases. In some cases, genetic testing may help confirm a diagnosis.
Characterized by progressive muscle loss and weakness, our tests can detect the genetic mutations that cause the most common forms.
The increasing prevalence of neurodegenerative diseases has fueled the need for advanced research into therapeutic solutions and related neurodegenerative biomarkers.
Contact a Labcorp representative to learn more about how we can help meet your neurology testing needs